Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-23-000170

Director acquired 2,859 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STARR CHRISTOPHER M · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-31 Exercise or conversion : show line 1 in the form +2,859 15,730 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-12-31 Exercise or conversion : show line 2 in the form Restricted Stock Units −2,859 0 D
Loading xslF345X03/rdgdoc.xml…